Identification of the stakeholders which are likely to use, benefit or assess the health tech product in development and which opinions, publications and priorities should be identified and considered.
Identification of the stakeholders which are likely to use, benefit or assess the health tech product in development and which opinions, publications and priorities should be identified and considered.
A critical aspect of pharmaceutical development processes and applications. CMC includes bulk drug substance chemical…
View definitionGood Manufacturing Practice. This is a recognised standard for pharmaceutical processing and manufacture ensuring medicinal…
View definitionabout us
our expertise
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this site, you will need to enable or disable cookies again.
This site uses Google Analytics to collect anonymous information such as the number of visitors to the site and the most popular pages.
Keeping this cookie activated helps us to improve our website.
Please first enable strictly necessary cookies so that we can save your preferences !
This site uses Google Analytics to collect anonymous information such as the number of visitors to the site and the most popular pages.
Keeping this cookie activated helps us to improve our website.
Please first enable strictly necessary cookies so that we can save your preferences !
More information about our Privacy Policy